1. Home
  2. MIND vs CING Comparison

MIND vs CING Comparison

Compare MIND & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$6.45

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.53

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIND
CING
Founded
1987
2012
Country
United States
United States
Employees
N/A
13
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
93.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MIND
CING
Price
$6.45
$5.53
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.50
AVG Volume (30 Days)
201.5K
394.5K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.31
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$3.20
52 Week High
$14.50
$11.89

Technical Indicators

Market Signals
Indicator
MIND
CING
Relative Strength Index (RSI) 39.33 41.87
Support Level N/A $4.94
Resistance Level $9.22 $6.85
Average True Range (ATR) 0.47 0.44
MACD -0.20 0.02
Stochastic Oscillator 19.18 24.34

Price Performance

Historical Comparison
MIND
CING

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: